- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.04. | Sharps Technology Inc. - 10-K/A, Annual Report | 3 | SEC Filings | ||
| 14.04. | Sharps Technology Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 04.04. | Sharps Technology Inc. - 8-K, Current Report | 9 | SEC Filings | ||
| 28.03. | Sharps Technology Inc. - 8-K, Current Report | 8 | SEC Filings | ||
| 27.03. | Sharps Technology Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| 14.03. | Sharps Technology Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.03. | Sharps Technology Inc: Sharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary | 215 | GlobeNewswire (Europe) | NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our... ► Artikel lesen | |
| 30.01. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 29.01. | Sharps Technology Inc: Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering | 2 | GlobeNewswire (USA) | ||
| 28.01. | Sharps Technology tumbles on pricing underwritten public offering | 6 | Seeking Alpha | ||
| 28.01. | Sharps Technology sets $20 million public offering price | 5 | Investing.com | ||
| 28.01. | Sharps Technology Inc: Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering | 1 | GlobeNewswire (USA) | ||
| 22.01. | Sharps Technology Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 10.01. | Sharps Technology Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 23.12.24 | Sharps Technology files to sell 37,013 shares of common stock for holders | 6 | Seeking Alpha | ||
| 23.12.24 | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.12.24 | Sharps Technology Inc: Sharps Technology's CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue | 202 | GlobeNewswire (Europe) | Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery scheduleInitial... ► Artikel lesen | |
| 05.12.24 | Sharps Technology Inc: Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard | 4 | GlobeNewswire (USA) | ||
| 05.12.24 | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.11.24 | Sharps Technology Inc: Sharps Regains Nasdaq Listing Compliance | 216 | GlobeNewswire (Europe) | NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 25,350 | +3,26 % | EQS-Adhoc: STRATEC SE: STRATEC berichtet vorläufige Geschäftszahlen für 2024, gibt Ausblick für 2025 und verschiebt Geschäftsbericht 2024 | EQS-Ad-hoc: STRATEC SE / Schlagwort(e): Vorläufiges Ergebnis/Prognose
STRATEC BERICHTET VORLÄUFIGE GESCHÄFTSZAHLEN FÜR 2024, GIBT AUSBLICK FÜR 2025 UND VERSCHIEBT GESCHÄFTSBERICHT... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,140 | +3,70 % | Sernova Biotherapeutics Inc: Sernova closes $4-million term loan from Navigate | ||
| ATOSSA THERAPEUTICS | 0,639 | -1,69 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,800 | -1,96 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,012 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,312 | -1,89 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,972 | +2,86 % | CytoSorbents Gains $1.7M Via NJEDA Tax Credit Sale To Fund Strategic Growth | ||
| VERU | 0,496 | +2,52 % | Veru Aktie: Bedeutet das eine Neuausrichtung? | Die Veru-Aktie verliert weiter an Wert, doch Analysten bleiben optimistisch aufgrund vielversprechender Medikamentenentwicklungen. Wird der Tiefpunkt bald erreicht? Die Veru-Aktie setzt ihre Abwärtsspirale... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VOLITIONRX | 0,483 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 0,378 | +5,29 % | Ekso Bionics Holdings, Inc.: Bionic P&O Chosen as First Distributor of Ekso Indego Personal Within the Orthotics & Prosthetics Industry | ||
| IMUNON | 0,795 | +2,58 % | Imunon, Inc.: IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting | ||
| BEYOND AIR | 0,190 | +3,83 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| FRESENIUS | 39,800 | +0,81 % | Fresenius SE Aktie: Leichte Erholung im Fokus | Fresenius notiert nahe dem Jahreshoch mit soliden technischen und fundamentalen Signalen. Analysten sehen weiteres Kurspotenzial trotz hoher Verschuldung. Die Fresenius-Aktie zeigt sich am Donnerstag... ► Artikel lesen |
Das Unternehmen SHARPS TECHNOLOGY INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,028 Euro und damit -3,44 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHARPS TECHNOLOGY INC finden Sie auf Wallstreet Online.
